- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Baird Medical Investment Holdings Limited(BDMD)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for BDMD
11/13/2026: BDMD (1-star) is currently NOT-A-BUY. Pass it for now.
Baird Medical Investment Holdings Limited is a specialized medical technology company that develops and sells microwave ablation devices for minimally invasive tumor treatments. The company benefits from high gross profit margins and a razor-and-blade model anchored by recurring consumable needle utilization. Its primary growth catalyst lies in international expansion, highlighted by U.S. commercial leadership appointments and regulatory filings for advanced ablation systems. However, the business faces significant headwinds, including heavy revenue dependence on Mainland China procurement trends, uncollected receivables, and recent operating losses. Investors should monitor U.S. market adoption progress and cash flow stabilization while weighing its high volatility and speculative risk profile.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While international expansion initiatives offer growth potential, recent revenue contraction and execution hurdles introduce uncertainty. |
| Weak fit | The stock has experienced sharp downward price pressure and trades near historical lows, making it conditional on a confirmed technical upturn signal. | |
| Value investor | Mixed fit | High gross margins provide an appealing baseline, but ongoing operating losses and cash burn offset deep-value appeal. |
| Dividend investor | Weak fit | The company does not pay dividends, directing all capital toward product innovation and global market entry. |
| Low-risk investor | Weak fit | High share price volatility, regulatory exposure, and financial swings present risks unsuited for conservative risk profiles. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock has shown wide trading ranges and steep downward swings, heightening near-term risk. |
| Valuation risk | Medium / high | Market sentiment has shifted heavily, discounting the equity amidst volatile earnings execution. |
| Competition risk (Medtronic and multinational medical device giants) | High | Well-capitalized competitors can leverage extensive distribution networks to bundle products and crowd out smaller players. |
| Business quality | Medium | Robust product gross margins reflect solid unit economics, though constrained by volatile cash collections. |
| Dividend income | Low / none | No payouts are distributed to shareholders. |
| Execution risk | High | Success depends heavily on executing the international commercial transition into Western markets smoothly. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 2.91M USD | Price to earnings Ratio - | 1Y Target Price 4 |
Price to earnings Ratio - | 1Y Target Price 4 | ||
Volume (30-day avg) 33.2M shares | Beta -0.99 | 52 Weeks Range 0.07 - 3.70 | Updated Date 11/15/2026 |
52 Weeks Range 0.07 - 3.70 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.55 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Devices
- BUY participation
- 62.5%
- Active BUY / eligible
- 5 / 8
- 30-Day BUY Count Change
- +3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Steep Decline
The stock price has dropped sharply with strong downward pressure.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -21.36% | Avg. Invested days 13 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Microwave Ablation Devices and Generators | Sale of durable capital equipment hardware to hospitals and medical centers. | This serves as the initial equipment placement phase of their business model. |
| Microwave Ablation Needles and Disposables | Consumable needle sales utilized during repeated tumor ablation procedures. | This represents the recurring razor-and-blade revenue stream tied directly to hospital procedure volumes. |
| Geographic Exposure (Mainland China & International) | Product sales via direct channels in domestic markets and third-party distributors spanning Hong Kong, Southeast Asia, and expanding global territories. | Regional policy changes heavily impact domestic results, making international diversification critical. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 0.65 | Enterprise Value 21.65M | Price to Sales(TTM) 0.12 |
Enterprise Value 21.65M | Price to Sales(TTM) 0.12 | ||
Enterprise Value to Revenue 0.88 | Enterprise Value to EBITDA 5.91 | Shares Outstanding 32.11M | Shares Floating 6.50M |
Shares Outstanding 32.11M | Shares Floating 6.50M | ||
Percent Insiders 86.61 | Percent Institutions 0.94 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

